Hepatic Artery Infusion Pump Combined With Systemic Chemotherapy for Patients With Liver Metastases From Breast Carcinoma
Conclusions: HAI gemcitabine plus FUDR combined with systemic chemotherapy is effective in achieving a high local response and prolonging mOS for patients with BCLM and is associated with a relatively low rate of toxicity.PMID:34657511 | DOI:10.1177/15330338211051552
Source: Technology in Cancer Research and Treatment - Category: Cancer & Oncology Authors: Hong-Bing Shi Wei-Guang Qiang Wei-Liang Zhu Ye Yuan Jun-Jun Wang Jie-Min Zhao Wen-Wei Hu Source Type: research
More News: Angiography | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Chemotherapy | Hepatocellular Carcinoma | Liver | Liver Cancer | Palliative | Study | Toxicology | Urology & Nephrology